Cancer Center of GBMC

Baltimore, Maryland 21204

We've found

1 trials

at this facility

Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate

Status: Enrolling, Phase III
Updated: 3/28/2008

from

Baltimore, MD

Use our guide to learn which trials are right for you!